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A RETROSPECTIVE STUDY OF HISTOPATHOLOGICAL FINDINGS IN 894 CASES OF MEGACOLON.
WHAT IS THE RELATIONSHIP BETWEEN MEGACOLON AND COLONIC CANCER?
Sérgio Britto GARCIA(1), Alexandre Luis ARANHA(1), Fabio Rogério Brosci GARCIA(1), Filipe Volpe BASILE(1), André Péra Marques PINTO(1),
Enio Chaves de OLIVEIRA(2) & Sérgio ZUCOLOTO(1)
SUMMARY
Patients with megaesophagus (ME) have increased prevalence of cancer of the esophagus. In contrast, a higher incidence of
colorectal cancer is not observed in patients with megacolon (MC). MC is very common in some regions of Brazil, where it is mainly
associated with Chagas disease. We reviewed the pathology records of surgical specimens of all patients submitted for surgical
resection of MC in the Hospital das Clínicas of the Faculty of Medicine of Ribeirão Preto (HC-FMRP), from the University of São
Paulo. We found that 894 patients were operated from 1952 until 2001 for MC resection. Mucosal ulcers, hyperplasia and chronic
inflammation were frequently found, while polyps were uncommon. No patients with MC presented any type of colonic neoplasm.
This observation reinforces the hypothesis that MC has a negative association with cancer of the colon. This seems to contradict the
traditional concept of carcinogenesis in the colon, since patients with MC presents important chronic constipation that is thought to
cause an increase in risk for colon cancer. MC is also associated with other risk factors for cancer of colon, such as hyperplasia,
mucosal ulcers and chronic inflammation. In ME these factors lead to a remarkable increase in cancer risk. The study of mucosal cell
proliferation in MC may provide new insights and useful information about the role of constipation in colonic carcinogenesis.
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INTRODUCTION
Chagas disease is caused by the hemoflagellate Trypanosoma cruzi.
The infection has an acute phase that lasts for two months and the patient
may present a few non-specific symptoms. Afterwards the patient goes
into chronic phase of the disease that is defined by positive serological
tests. Most infected people remain asymptomatic for life. After a period
of one to two decades in chronic phase, usually, 7-10% of patients will
show digestive manifestations. Megaesophagus (ME) and megacolon
(MC) are the most important disturbances of the digestive form of Chagas
disease. Physiopathology of ME and MC is attributed to the destruction
of neural cells of the enteric plexuses of the digestive tube5 and the process
of neurons destruction is related to nitric oxide8. Motility disturbances
and achalasia of internal anal sphincter lead to latter enlargement of the
colon and constipation. The rectum and the sigmoid colon are the most
compromised segments. Clinically patients with chagasic megacolon
present severe and prolonged constipation of many days (up to 60 days)
for decades. Literature has reported constipation as an important factor
in the pathogenesis of colorectal cancer because it prolongs the contact
of carcinogens in the stools with the mucosa13,14,16. Conversely, a higher
incidence of colorectal cancer is not observed in patients with megacolon.
In fact there is a long-standing observation among many Brazilian
physicians that carcinoma of the colon is unlikely to occur in chagasic
MC. Recently it has been published one case of association between
colon cancer and MC2; in this article the authors also report a large review
of the literature that confirms a low frequency of this association. There
is also a recent report of two patients with chagasic MC that presented
adenocarcinomas, but in these cases the tumours were not actually located
in the dilated segment of the colon23. Furthermore, none of the few other
retrospective studies on complications of MC mention cases of
cancer9,10,15,18. These studies report a small number of cases and, for this
reason, it is difficult to gather enough collective information to produce
meaningful data on this issue. In order to provide additional data and to
contribute to a more comprehensive assessment and understanding of
the association between cancer and MC, we reviewed the pathology
records of surgical specimens of all patients submitted to colectomy due
to the presence of MC in the Hospital of the Faculty of Medicine of
Ribeirão Preto (FMRP), University of São Paulo. This is a major reference
hospital for patients with Chagas disease, and is located at the centre of
an old and heavily endemic region for Chagas disease.
MATERIAL AND METHODS
We reviewed the pathology records of surgical specimens of all
patients submitted for surgical resection of MC in the HC-FMRP from
1955 to 2001 in the HC-FMRP. The data recorded until 1998 were:
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number of cases, causes, sex, age and histopathological findings. From
1999 to 2001 we performed a study for the number of cases of MC and
a search for the presence or absence of cancer in then.
RESULTS
A total of 802 patients were operated for MC resection from 1955 to
1998 at our Institution. Of these patients, 95.4% were chiasmic, 1.2%
had congenital MC and 3.4% had unknown causes of MC. The patients
ranged in age from 1 month to 80 years, but 70% of them were older
than 45 years (Table 1). Men were less often affected than women (42%
against 58%, respectively). In the present study no patients with MC
presented cancer of the colon. Histopathological alterations frequently
found were: mucosal hyperplasia (found in 54.8% of patients) ulcers
(12.0%), chronic inflammation (28.3%) and atrophic mucosa (2.6%).
Intestinal polyps were uncommon and found in only 3 patients (0.4%).
Ninety-two patients were operated for MC resection from 1999 to
2001. None of them presented any type of colonic malignant neoplasm.
DISCUSSION
The study of the association between cancer and acquired MC may
provide useful data to clarify the pathogenesis of colonic cancer17. Our
observation reinforces the concept that MC has a negative association
with cancer of the colon. It is also in accordance with our previous
experimental observation of reduced frequency of colon tumours in rats
with MC treated with carcinogens7. This seems to contradict the
traditional concept of carcinogenesis in the colon, since patients with
MC have various risk factors for colon cancer. First of all, they have
important chronic constipation that has been considered as a risk factor
for cancer, as it provides a longer contact of dietary carcinogens with
the mucosa3. Furthermore, most of the cases of MC are located in the
distal portion of the large bowel9, where the cancer of colon is more
commonly found, and most of the patients are over fifty years old, and,
therefore, belong to a age group of major risk for colon cancer. Finally it
is considered that mucosal hyperplasia, ulcers and chronic inflammation
are factors that increase the risk for cancer in many organs. In ME these
factors, associated with luminal stasis, lead to a remarkable increase in
cancer risk29. Since the nineteenth century the literature has demonstrated
a significant positive association between esophageal cancer and ME
that has been extensively confirmed in more recent studies25,28,29. There
is also a report of a patient that presented leiomyosarcoma of the
esophagus with chagasic megaesophagus1. In a review in the FMRP, we
found a frequency of 3.1% of esophageal cancer in 364 patients operated
for ME resection (unpublished data). Interestingly it has been recently
observed that there appears to be a positive association between Chagas
disease and uterine leiomyoma19.
Thus, the relationship between T.cruzi infection and cancer incidence
is rather complex. It is known that T. cruzi produces persistent chronic
inflammatory process along the digestive tube with uneven distribution27.
Some chronic infections by viruses, bacteria and parasites are well known
as risk factors in human cancers11. Why chronic infection by T.cruzi
does not behave similarly? Molecular mechanisms involved in
carcinogenesis related to chronic inflammation are not well understood.
Recent data suggest a possible role of the nitric oxide6 in the multistep
carcinogenesis mechanism6 that may be also shared in some way by
chronic T. cruzi infection7,21. It has been reported that rats chronically
infected with T. cruzi have a lower incidence of 1,2-dimethylhydrazine-
induced colon cancer22 and infection by T.cruzi can cause important
tumoricidal effect4. Similarly, it has been reported that some protozoans
such as Toxoplasma gondii and Besnotia jellisoni may increase resistance
against tumor12. Thus, a striking possible role of T. cruzi infection against
the development of tumours by increasing the immune resistance is
stimulated by our study.
The apparent negative correlation between human MC and colon
cancer needs to be confirmed by further larger studies, preferably
prospective and multidisciplinary. It also highlights the necessity for
more research on the role of constipation in increasing colon cancer
risk, which remains controversial, with some studies dismissing it13,24
and others supporting it16,20,26. Our data add weight to the view that
constipation is at least not always related to increased risk of colon cancer.
Since constipation is highly prevalent in many countries and many clinical
and nutritional attitudes are based in accepting its role as a risk factor for
colon cancer, this aspect deserves more attention in basic and clinical
research.
RESUMO
Um estudo retrospectivo dos achados histopatológicos
em 894 casos de megacólon. Qual é a relação entre
megacólon e o câncer de cólon ?
Pacientes com megaesôfago (ME) possuem incidência aumentada
de câncer de esôfago. Em contraste, há poucos relatos na literatura de
associação entre megacólon (MC) e câncer de cólon. O MC é muito
comum em algumas regiões do Brasil, e na maioria das vezes, está
associado à Doença de Chagas. Nós reavaliamos os arquivos de patologia
de peças cirúrgicas de todos os pacientes submetidos à ressecção de MC
no Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
(HC-FMRP), da Universidade de São Paulo. Encontramos o número de
894 pacientes que foram operados de 1952 até 2001 para a ressecção do
MC. Úlceras da mucosa, hiperplasia e inflamação crônica foram
frequentemente encontrados, enquanto pólipos foram incomuns. Nenhum
Table 1
Age distribution of patients with megacolon, from 802 patients operated for
megacolon resection in the Faculty of Medicine of Ribeirão Preto, University
of São Paulo, Brazil, from 1955 to 1998
Age Number of cases of megacolon
< 20 22
20 - 29 62
30 - 39 163
40 - 49 244
50 - 59 195
60 - 69 94
> 70 22
Total 802
Mean 46.01
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paciente com MC apresentou qualquer tipo de neoplasia do cólon. Essa
observação reforça a hipótese de que o MC tem uma associação negativa
com câncer de cólon. Isso parece contradizer o conceito tradicional de
carcinogênese do cólon, uma vez que pacientes com MC apresentam
constipação crônica importante, a qual é tida como uma causa que
aumenta o risco de câncer de cólon. MC também está associado a outros
fatores de risco para o câncer de cólon, como hiperplasia, úlceras da
mucosa e inflamação crônica. No megaesôfago (ME), tais fatores
aumentam o risco de câncer esofágico. O estudo da proliferação celular
da mucosa no MC pode fornecer informações úteis sobre o papel da
constipação na carcinogênese colônica.
REFERENCES
1. ADAD, S.J.; ETCHEBEHERE, R.M.; HAYASHI, E.M. et al. - Leiomyosarcoma of the
esophagus in a patient with chagasic megaesophagus: case report and literature review.
Amer. J. trop. Med. Hyg., 60: 879-881, 1999.
2. ADAD, S.J.; ETCHEBEHERE, R.M.; ARAÚJO, J.R. et al. - Association of chagasic
megacolon and cancer of the colon: case report and review of the literature. Rev.
Soc. bras. Med. trop., 35: 63-68, 2002.
3. BURKITT, D.P. - Cancer of the GI tract: colon, rectum, anus. Epidemiology and etiology.
J. Amer. med. Ass., 231: 517-518, 1975.
4. CABRAL, H.R.A. - The tumoricidal effect of Trypanosoma cruzi: its intracellular cycle
and the immune response of the host. Med. Hypotheses, 54: 1-6, 2000.
5. FARIA, C.R.; MELO-SOUZA, S.E.; RASSI, A. & LIMA, A.F. - Evidências
eletromiográficas de desnervação motora em pacientes na fase aguda da doença de
Chagas. Rev. goiana Med., 25: 153-155, 1979.
6. FEIG, D.I.; REID, T.M. & LOEB, L.A. - Reactive oxygen species in tumorigenesis.
Cancer Res., 54 (7 suppl.):1890s-1894s, 1994.
7. GARCIA, S.B.; OLIVEIRA, J.S.M.; PINTO, L.Z.; MUCCILLO, G. & ZUCOLOTO, S.
- The relationship between megacolon and carcinoma of the colon: an experimental
approach. Carcinogenesis, 17: 1777-1779, 1996.
8. GARCIA S.B.; PAULA, J.S.; GIOVANNETTI, G.S. et al. - Nitric oxide is involved in
the lesions of the peripheral autonomic neurons observed in the acute phase of
experimental Trypanosoma cruzi infection. Exp. Parasit., 93: 191-197, 1999.
9. GATTUSO, J.M.; KAMM, M.A. & TALBOT, I.C. - Pathology of idiopathic megarectum
and megacolon. Gut, 41: 252-257, 1997.
10. HENRY, M.A.C.A.; MENDES, E.F.; PRADO, R.G. et al. - Megacólon: análise de 200
pacientes submetidos a tratamento cirúrgico. Rev. goiana Med., 35: 25-33, 1989.
11. HERRERA, L.A. & OSTROSKY-WEGMAN, P. - Do helminths play a role in
carcinogenesis? Trends Parasit., 17: 172-175, 2001.
12. HIBBS Jr., J.B.; LAMBERT Jr., L.H. & REMINGTON, J.S. - Resistance to murine
tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii
and Besnoitia jellisoni. J. infect. Dis., 124: 587-592, 1971.
13. JACOBS, E.J. & WHITE, E. - Constipation, laxative use, and colon cancer among middle-
aged adults. Epidemiology, 9: 385-391, 1998.
14. KUNE, G.A.; KUNE, S.; FIELD, B. & WATSON, L.F. - The role of chronic constipation,
diarrhea, and laxative use in the etiology of large-bowel cancer. Data from the
Melbourne Colorectal Cancer Study. Dis. Colon Rect., 31: 507-512, 1988.
15. LANE, R.H.S. & TODD, I.P. - Idiopathic megacolon: a review of 42 cases. Brit. J.
Surg., 64: 307-310, 1977.
16. LE MARCHAND, L. - Constipation and colon cancer. Epidemiology, 9: 371-372, 1998.
17. LOPES, E.R. - Megaesôfago, megacólon e câncer. Rev. Soc. bras. Med. trop., 21: 91-
94, 1988.
18. MENESES, A.C.O.; LOPES, M.A.B.; ROCHA, A. et al. - Megas e câncer. Câncer de
intestino grosso em chagásicos com megacólon. Arch. Gastroent. (S. Paulo), 26:
13-16, 1989.
19. MURTA, E.F.; OLIVEIRA, G.P.; PRADO, F.O. et al. - Association of uterine leiomyoma
and Chagas´disease. Amer. J. trop. Med. Hyg, 66: 321-324, 2002.
20. NAKAMURA, G.J.; SCHNEIDERMAN, L.J. & KLAUBER, M.R. - Colorectal cancer
and bowel habits. Cancer, 54: 1475-1477, 1984.
21. NY, L.; PERSSON, K.; LARSSON, B. et al. - Localization and activity of nitric oxide
synthases in the gastrointestinal tract of Trypanosoma cruzi infected mice. J.
Neuroimmunol. (Amst.), 99: 27-35, 1999.
22. OLIVEIRA, E.C.; LEITE, M.S.B.; MIRANDA, J.A.R. et al. - Chronic Trypanosoma
cruzi infection associated with low incidence of 1,2-dimethylhydrazine-induced colon
cancer in rats. Carcinogenesis, 22: 737-740, 2001.
23. OLIVEIRA, E.C.; LEITE, M.S.; OSTERMAYER, A.L.; ALMEIDA, A.C. & MOREIRA,
H. - Chagasic megacolon associated with colon cancer. Amer. J. trop. Med. Hyg.,
56: 596-598, 1997.
24. POTTER, J.D. - Nutrition and colorectal cancer. Cancer Causes Control, 7: 127-146,
1996.
25. SANDLER, R.S.; NYREN, O.; EKBOM, A. et al. - The risk of esophageal cancer in
patients with achalasia. A population-based study. J. Amer. med. Ass., 274: 1359-
1362, 1995.
26. SONNENBERG, A. & MULLER, A.D. - Constipation and cathartics as risk factors of
colorectal cancer: a meta-analysis. Pharmacology (Basel), 47 (suppl. 1): 224-233,
1993.
27. TAFURI, W.L.; LIMA PEREIRA, F.E.; BOGLIOLO, L. & RASO, P. - Lesões do sistema
nervoso autônomo e do tecido muscular estriado esquelético na fase crônica da
tripanosomose cruzi experimental. Estudos ao microscópico óptico e eletrônico. Rev.
goiana Med., 25: 61-67, 1979.
28. WYCHULIS, A.R.; WOOLAM, G.L.; ANDERSEN, H.A. & ELLIS Jr., F.H. - Achalasia
and carcinoma of the esophagus. J. Amer. med. Ass., 215: 1638-1641, 1971.
29. ZUCOLOTO, S. & REZENDE, J.M. - Mucosal alterations in human chronic chagasic
esophagopathy. Digestion, 47: 138-142, 1990.
Received: 20 August 2002
Accepted: 12 February 2003
